Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E15.79 EPS (ttm)3.32 Insider Own0.04% Shs Outstand5.61B Perf Week3.15%
Market Cap297.65B Forward P/E11.84 EPS next Y4.42 Insider Trans-10.25% Shs Float5.59B Perf Month21.35%
Income18.90B PEG1.16 EPS next Q0.85 Inst Own67.50% Short Float1.17% Perf Quarter12.06%
Sales69.34B P/S4.29 EPS this Y-33.10% Inst Trans0.21% Short Ratio2.07 Perf Half Y36.10%
Book/sh13.49 P/B3.88 EPS next Y4.86% ROA11.60% Target Price48.33 Perf Year40.75%
Cash/sh5.23 P/C10.02 EPS next 5Y13.60% ROE27.60% 52W Range33.36 - 54.94 Perf YTD42.35%
Dividend1.56 P/FCF14.08 EPS past 5Y2.20% ROI7.60% 52W High-4.62% Beta0.73
Dividend %2.98% Quick Ratio1.20 Sales past 5Y-3.00% Gross Margin65.40% 52W Low57.07% ATR1.65
Employees78500 Current Ratio1.40 Sales Q/Q134.40% Oper. Margin28.30% RSI (14)66.88 Volatility3.15% 3.12%
OptionableYes Debt/Eq0.53 EPS Q/Q782.70% Profit Margin27.70% Rel Volume2.34 Prev Close54.00
ShortableYes LT Debt/Eq0.48 EarningsNov 02 BMO Payout45.20% Avg Volume31.60M Price52.40
Recom2.60 SMA207.58% SMA5015.94% SMA20026.88% Volume72,660,760 Change-2.96%
Nov-19-21Initiated BMO Capital Markets Outperform $60
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Nov-30-21 07:26AM  
07:00AM  
06:55AM  
06:27AM  
06:00AM  
05:11AM  
04:09AM  
03:30AM  
01:24AM  
12:58AM  
Nov-29-21 04:56PM  
04:46PM  
04:37PM  
04:19PM  
04:00PM  
02:48PM  
02:28PM  
02:14PM  
02:00PM  
01:42PM  
01:34PM  
01:14PM  
01:02PM  
01:00PM  
12:46PM  
12:25PM  
12:05PM  
11:41AM  
11:40AM  
11:36AM  
11:07AM  
10:49AM  
10:18AM  
10:15AM  
10:06AM  
10:06AM  
10:06AM  
09:53AM  
09:52AM  
09:46AM  
09:23AM  
08:53AM  
08:17AM  
08:17AM  
08:03AM  
05:09AM  
04:59AM  
03:24AM  
01:26AM  
Nov-28-21 06:30PM  
02:58PM  
11:14AM  
10:30AM  
06:10AM  
Nov-26-21 08:57PM  
05:32PM  
03:56PM  
03:53PM  
02:47PM  
02:42PM  
02:33PM  
02:12PM  
02:09PM  
01:56PM  
01:35PM  
01:32PM  
01:24PM  
01:16PM  
01:06PM  
11:40AM  
11:06AM  
10:53AM  
10:40AM  
10:23AM  
09:42AM  
09:30AM  
09:27AM  
09:17AM  
08:16AM  
07:43AM  
07:30AM  
07:15AM  
07:13AM  
06:54AM  
02:26AM  
01:52AM  
01:15AM  
Nov-25-21 03:34PM  
08:56AM  
07:12AM  
07:07AM  
06:59AM  
Nov-24-21 04:55PM  
04:20PM  
04:18PM  
11:00AM  
10:30AM  
10:00AM  
09:31AM  
06:30AM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hwang AngelaGroup PresidentNov 12Sale49.6026,1701,298,0021Nov 15 05:32 PM
Dolsten MikaelPresident R&DNov 11Option Exercise25.13199,5485,014,926339,506Nov 15 05:40 PM
YOUNG JOHN DGroup PresidentNov 11Sale50.06150,0007,508,732312,704Nov 12 06:08 PM
Dolsten MikaelPresident R&DNov 11Sale50.2959,6643,000,647279,842Nov 15 05:40 PM
DAMICO JENNIFER B.SVP & ControllerAug 13Sale48.301,66180,2269,769Aug 16 08:12 PM
DAMICO JENNIFER B.SVP & ControllerJul 30Sale42.862,500107,15011,430Aug 02 07:02 PM
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM